Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aalberts NV | AALB | Mar 31, 2025 | 31.20 | -2.92 |
ABN AMRO Bank N.V. | ABN | Mar 31, 2025 | 19.36 | -1.65 |
Accsys Technologies | AXS | Mar 31, 2025 | 0.52 | -2.80 |
ADYEN N.V. EO-,01 | ADYEN | Mar 31, 2025 | 1 406.00 | -2.97 |
Aedifica NV | AED | Mar 31, 2025 | 62.45 | -0.56 |
Aegon Ltd. | AGN | Mar 31, 2025 | 6.05 | -0.72 |
AEX-index | AEX | Mar 31, 2025 | 898.80 | -0.95 |
AFC Ajax NV | AJAX | Mar 31, 2025 | 10.00 | +0.60 |
Agility Capital Holding Inc. | AGIL | Mar 31, 2025 | 3.04 | +4.83 |
AIR FRANCE -KLM | AF | Mar 31, 2025 | 8.53 | -6.61 |
Akzo Nobel | AKZA | Mar 31, 2025 | 56.68 | +0.04 |
Alfen NV | ALFEN | Mar 31, 2025 | 12.41 | -2.93 |
Allfunds Group Plc | ALLFG | Mar 31, 2025 | 5.27 | -2.68 |
Almunda Professionals N.V | AMUND | Mar 31, 2025 | 1.09 | 0.00 |
Alumexx N.V. | ALX | Mar 31, 2025 | 1.48 | +7.25 |
AMG Critical Materials N.V | AMG | Mar 31, 2025 | 14.28 | -8.34 |
Amsterdam Commodities NV | ACOMO | Mar 31, 2025 | 21.40 | +0.23 |
AP Alternative Assets | AAA | Mar 31, 2025 | 4.60 | -6.12 |
APERAM | APAM | Mar 31, 2025 | 29.90 | -1.39 |
Arcadis | ARCAD | Mar 31, 2025 | 47.00 | -2.33 |
ArcelorMittal SA | MT | Mar 31, 2025 | 26.47 | -1.31 |
Arcona Property Fund N.V. | ARCPF | Mar 31, 2025 | 7.00 | 0.00 |
ASCX-index | ASCX | Mar 31, 2025 | 1 354.72 | -1.93 |
ASM International NV | ASM | Mar 31, 2025 | 415.40 | -3.75 |
ASML Holding NV | ASML | Mar 31, 2025 | 606.00 | -3.13 |
ASR NEDERLAND N.V.EO-,16 | ASRNL | Mar 31, 2025 | 52.98 | -0.49 |
Avantium N.V. | AVTX | Mar 31, 2025 | 1.30 | -4.82 |
Azerion Group N.V. | AZRN | Mar 31, 2025 | 1.37 | -0.58 |
B&S Group SA | BSGR | Mar 31, 2025 | 4.01 | -1.35 |
Banijay Group N.V. | BNJ | Mar 31, 2025 | 9.25 | +0.54 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.